Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ascorbic acid, commonly known as Vitamin C, is a water-soluble essential vitamin and potent antioxidant. It serves as a critical cofactor for several enzymes, including prolyl hydroxylases involved in collagen synthesis and enzymes required for catecholamine production. Beyond its role in preventing scurvy, ascorbic acid is investigated for its ability to modulate oxidative stress and inflammation in conditions such as sepsis, chronic obstructive pulmonary disease (COPD), and chronic kidney disease. Emerging research highlights its role as an epigenetic modulator; it acts as a cofactor for Ten-Eleven Translocation (TET) methylcytosine dioxygenases, promoting DNA demethylation by converting 5-methylcytosine to 5-hydroxymethylcytosine. This mechanism is being explored as a therapeutic strategy in cancers with epigenetic aberrations, such as clear cell renal cell carcinoma (ccRCC). It is also studied for neuroprotective potential in glaucoma and Parkinson's disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ascorbic acid.